In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Aurobindo supplies AZ with generics for emerging markets

Executive Summary

Marking its second Big Pharma out-licensing to date, Aurobindo Pharma Ltd. (generic drugs, APIs, and organic intermediates) has agreed to nonexclusively license AstraZeneca PLC 20-25 solid dosage and sterile branded generic products to sell in 40 emerging territories.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies